This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Sirius JV will be owned 51% by Sirius and 49% by Adani
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Innovent will supply sintilimab for the collaborated clinical trial
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
The establishment of the facility demonstrates the company's commitment to delivering differentiated solutions to gynecology and pediatrics challenges
BioVaxys has been granted exclusivity while the parties work in good faith on the drafting of a definitive agreement
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Leading USA based genetic testing brand officially enters the Indian market
Subscribe To Our Newsletter & Stay Updated
